Skip to content
sellWeak10b5-1 plan

Floyd F. Petersen sold $13k of AMPH

director at Amphastar Pharmaceuticals, Inc.. 500 shares at an average of $25.67, traded Jun 2, 2025, filed Jun 4, 2025.

Warning score
0
Value
$13k
500 shares
Holdings after
72,909
-1% from before
From 52-week low
+10%
low $22.99, close $25.38
From 52-week high
-52%
high $53.40, as of Jun 2, 2025

Score components

  • Role
    Director
    +15
  • Trade size
    $13k at market
    0
  • Share of holdings sold
    Sold 0.7% of holdings
    0
  • Cluster
    No other insider selling within 14 days
    0
  • 10b5-1 plan
    Pre-scheduled under a 10b5-1 plan
    -20

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m -10.3%, 3m +13.7%, 6m +6.7%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

AMPHOct 9, 2026 · close 26.62
Since filing Jun 4, 2025: +2.9%SPY +32.7% · excess -29.8%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001415889-25-015658, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Jun 2, 2025SOpen-market sale
Common Stock10b5-1
-500$25.67$13k72,909Jun 4, 2025
Jun 2, 2025AGrant or award
Common Stock10b5-1
+5,122$0.00$078,031Jun 4, 2025
Jun 2, 2025AGrant or award
Stock Option (right to buy)derivative10b5-1
+11,402$0.00$011,402Jun 4, 2025

Related signals

Other insiders at Amphastar Pharmaceuticals, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
20Weak
AMPHsell 210b5-1
Amphastar Pharmaceuticals, Inc.
William J Peters
CFO, EVP & TREASURER
$103k
4,139 shares
-2%
21Weak
AMPHsell 2
Amphastar Pharmaceuticals, Inc.
Rong Zhou
SENIOR EVP, PRODUCTION CENTER
$239k
10,000 shares
-6%
23Weak
AMPHsell
Amphastar Pharmaceuticals, Inc.
Rong Zhou
SENIOR EVP, PRODUCTION CENTER
$75k
3,187 shares
-2%
39Weak
AMPHsell 2
Amphastar Pharmaceuticals, Inc.
Richard K Prins
director
$162k
7,973 shares
-21%
7Weak
AMPHsell 210b5-1
Amphastar Pharmaceuticals, Inc.
William J Peters
CFO, EVP & TREASURER
$184k
8,180 shares
-5%
21Weak
AMPHsell 2
Amphastar Pharmaceuticals, Inc.
Rong Zhou
SENIOR EVP, PRODUCTION CENTER
$256k
9,787 shares
-7%
33Weak
AMPHsell 2
Amphastar Pharmaceuticals, Inc.
Floyd F. Petersen
director
$108k
4,163 shares
-6%
23Weak
AMPHsell 2
Amphastar Pharmaceuticals, Inc.
Richard K Prins
director
$113k
4,179 shares
-11%
30Weak
AMPHsell 2
Amphastar Pharmaceuticals, Inc.
Floyd F. Petersen
director
$442k
16,679 shares
-18%
0Weak
AMPHsell10b5-1
Amphastar Pharmaceuticals, Inc.
Floyd F. Petersen
director
$13k
500 shares
-1%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Floyd F. Petersen sold $13k of AMPH | InsiderTell